Index of reports
> Cases with Pancytopenia (81)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cytarabine where reactions include pancytopenia. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 81 Next >>
Possible Cytarabine side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-24
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Neoplasm Malignant, Cytomegalovirus Infection, Pancytopenia, Immunosuppression
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Start date: 2006-01-01
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cytarabine
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dacarbazine
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Start date: 2006-01-01
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Start date: 2006-01-01
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Dexamethasone
Possible Cytarabine side effects in male
Reported by a physician from Germany on 2012-08-24
Patient: male, weighing 95.8 kg (210.8 pounds)
Reactions: Abdominal Pain, Hypotension, Pancytopenia, Ascites, Faecaloma, Diarrhoea, Sepsis, Colitis, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 25 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-04
Clofarabine
Dosage: 25 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-03
Cytarabine
Dosage: 750 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-04
Cytarabine
Dosage: 750 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-03
Idarubicin HCL
Dosage: 7.5 mg/m2, unk
Start date: 2012-07-31
End date: 2012-08-02
Idarubicin HCL
Dosage: 7.5 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-29
End date: 2012-07-01
Other drugs received by patient: Vancomycin; Metronidazole; Piritramide; Enoxaparin Sodium; Zofran; Clonazepam; Sodium Chloride; Ciprofloxacin; Acyclovir; Ringer; Levothyroxine Sodium; Potassium Chloride; Ceftazidime; Noxafil
Possible Cytarabine side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-23
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Cytarabine side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-23
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Pancytopenia, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Cytarabine side effects in male
Reported by a physician from France on 2012-08-17
Patient: male, weighing 80.0 kg (176.0 pounds)
Reactions: Pancytopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 2050 mg, qd, days 8-10
Start date: 2012-04-26
End date: 2012-04-28
Cytarabine
Dosage: 1050 mg, qd, days 1-3
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-19
End date: 2012-04-21
Daunorubicin HCL
Dosage: 125 mg, qd, days 1-3
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-19
End date: 2012-04-21
Granocyte
Dosage: 410 mcg, qd, days 1-10
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-19
End date: 2012-04-28
Mozobil
Dosage: 240 mcg/kg, qd, days 1-3
Indication: Acute Myeloid Leukaemia
Start date: 2012-04-19
End date: 2012-04-21
Mozobil
Dosage: 240 mcg/kg, qd, days 8-10
Start date: 2012-04-26
End date: 2012-04-28
Mozobil
Possible Cytarabine side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Oophoritis, Pancytopenia, Cytomegalovirus Infection, Pyrexia, Pneumonia Cytomegaloviral
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Cytarabine
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Dexamethasone
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Radiotherapy
Possible Cytarabine side effects in 29 year old female
Reported by a health professional (non-physician/pharmacist) from Hungary on 2012-08-14
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Oophoritis, Cytomegalovirus Infection, Pancytopenia, Pyrexia, Pneumonia Cytomegaloviral
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bleomycin Sulfate
Indication: Hodgkin's Disease
Carboplatin
Indication: Hodgkin's Disease
Cisplatin
Indication: Hodgkin's Disease
Cytarabine
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Dexamethasone
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Gemcitabine Hydrochloride
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Rituximab
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Vinorelbine
Indication: Hodgkin's Disease
Other drugs received by patient: Radiotherapy
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-14
Patient: female, weighing 61.9 kg (136.2 pounds)
Reactions: Pancytopenia, Ascites
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 17 mg at day 2, 4, 6, 8, 10, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-01
End date: 2012-07-09
Cytarabine
Cytarabine
Dosage: 170 mg, 1 in 1 day
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-30
End date: 2012-07-09
Idarubicin HCL
Dosage: 17 mg at day 1, 3, 5
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-30
End date: 2012-07-04
Possible Cytarabine side effects in male
Reported by a physician from Italy on 2012-08-09
Patient: male
Reactions: Respiratory Failure, Chills, Pancytopenia, Condition Aggravated, Pyrexia, Lung Infection Pseudomonal, Septic Shock, Oxygen Saturation Decreased
Adverse event resulted in: death
Drug(s) suspected as cause:
Alkeran
Dosage: 234mg per day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-15
End date: 2012-02-15
Carmustine
Dosage: 500mg per day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-10
End date: 2012-02-10
Cytarabine
Dosage: 668mg per day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-11
End date: 2012-02-14
Etoposide
Dosage: 167mg per day
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-11
End date: 2012-02-14
Possible Cytarabine side effects in 66 year old male
Reported by a physician from France on 2012-08-07
Patient: 66 year old male, weighing 82.0 kg (180.4 pounds)
Reactions: Stenotrophomonas Infection, Coma, Device Related Infection, Pyrexia, Hypernatraemia, Loss of Consciousness, Malaise, Meningeal Disorder, Oedema Peripheral, Eye Movement Disorder, Blood Creatinine Increased, Cough, Hyperphosphataemia, Pleurisy, Pancytopenia, General Physical Health Deterioration, Aplasia, Convulsion, Nephrogenic Diabetes Insipidus, Neutropenia, Citrobacter Infection, Generalised Oedema, Hyperuricaemia, Myalgia, Weight Increased, Pleural Effusion, Crepitations, Thrombocytopenia, Jugular Vein Thrombosis, Candidiasis, Renal Failure Acute, Dyspnoea, Mucosal Inflammation, Diarrhoea, Monoparesis, Inflammation
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-28
End date: 2012-03-02
Etoposide
Dosage: 400 mg/m2 daily; uid/qd
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-28
End date: 2012-03-02
Melphalan Hydrochloride
Dosage: 250 mg total dose
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-03
Treanda
Dosage: 180 mg/m2 daily; 358.5 mg on day 1 + 2 of each cycle
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-02-27
End date: 2012-02-28
Treanda
Indication: non-Hodgkin's Lymphoma
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-06
Patient: female, weighing 61.9 kg (136.2 pounds)
Reactions: Pancytopenia, Ascites
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 17 mg at day 2, 4, 6, 8, 10, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-01
End date: 2012-07-09
Cytarabine
Dosage: unk, from day 1 to 10
Indication: Product Used FOR Unknown Indication
Cytarabine
Idarubicin HCL
Dosage: 17 mg at day 1, 3, 5
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-30
End date: 2012-07-04
Possible Cytarabine side effects in 65 year old male
Reported by a physician from France on 2012-08-06
Patient: 65 year old male, weighing 74.0 kg (162.8 pounds)
Reactions: Oedema Peripheral, Pancytopenia, Blood Creatinine Increased, Generalised Oedema, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: continuous infusion w/syringe driver 775 mg/day-day 2 to 5
Indication: Bone Marrow Conditioning Regimen
Etoposide
Dosage: 380 mg from day 2 to day 5
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-06
Rituximab
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-06
Treanda
Dosage: 200 mg/kg daily; day 1 and 2 of each cycle
Indication: Bone Marrow Conditioning Regimen
Start date: 2012-03-05
Other drugs received by patient: Melphalan Hydrochloride
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-03
Patient: female, weighing 61.9 kg (136.2 pounds)
Reactions: Pancytopenia, Ascites
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 17 mg at day 2, 4, 6, 8, 10, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-07-01
End date: 2012-07-09
Cytarabine
Dosage: unk, from day 1 to 10
Indication: Product Used FOR Unknown Indication
Cytarabine
Idarubicin HCL
Dosage: 17 mg at day 1, 3, 5
Indication: Acute Myeloid Leukaemia
Start date: 2012-06-30
End date: 2012-07-04
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-08-02
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Neutropenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
Clofarabine
Dosage: 19 mg, qd; day 1 to 5; cycles i and ii
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Cytarabine
Dosage: 1900 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin; Voriconazole
Possible Cytarabine side effects in 41 year old female
Reported by a health professional (non-physician/pharmacist) from Turkey on 2012-07-31
Patient: 41 year old female
Reactions: Uterine Leiomyoma, Tachycardia, Pancytopenia, Pallor, Uterine Haemorrhage
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m^2, unknown, unknown 2 q/m^2, unknown
Indication: Acute Myeloid Leukaemia
Daunorubicin HCL
Dosage: 45 mg/m^2, unknown, unknown
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Desogestrel and Ethinyl Estradiol
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-07-30
Patient: female, weighing 61.9 kg (136.2 pounds)
Reactions: Pancytopenia, Ascites
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Clofarabine
Dosage: 17 mg at day 2, 4, 6, 8, 10, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-01
Cytarabine
Dosage: unk, from day 1 to 10
Indication: Product Used FOR Unknown Indication
Cytarabine
Idarubicin HCL
Dosage: 17 mg at day 1, 3, 5
Indication: Product Used FOR Unknown Indication
Start date: 2012-06-30
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-07-27
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
Clofarabine
Dosage: 19 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Cytarabine
Dosage: 1900 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Other drugs received by patient: Meropenem; Vancomycin; Amphotericin B
Possible Cytarabine side effects in 50 year old female
Reported by a individual with unspecified qualification from Canada on 2012-07-26
Patient: 50 year old female
Reactions: Haemoptysis, Haemorrhage, Refractoriness To Platelet Transfusion, Petechiae, Pancytopenia, Febrile Neutropenia, Alveolitis Allergic, Panniculitis, Colitis, Laryngospasm, Klebsiella Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, on days 1-7
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2, on days 1-5
Indication: Acute Myeloid Leukaemia
Idarubicin Hydrochloride
Dosage: 12 mg/m2, on days 1-3
Indication: Acute Myeloid Leukaemia
Mitoxantrone Hydrochloride
Dosage: 10 mg/m2, on days 1-5
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-07-23
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Bronchopulmonary Aspergillosis, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
Clofarabine
Dosage: 19 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Cytarabine
Dosage: 1900 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
Other drugs received by patient: Meropenem; Vancomycin; Amphotericin B
Possible Cytarabine side effects in 11 year old female
Reported by a physician from United States on 2012-07-23
Patient: 11 year old female, weighing 54.7 kg (120.3 pounds)
Reactions: Pancytopenia, Pyrexia, Caecitis, Enterocolitis Infectious
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 1000 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-10
End date: 2012-06-04
Cytarabine
Etoposide
Dosage: 150 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-10
End date: 2012-06-04
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Myeloid Leukaemia
Start date: 2012-03-10
End date: 2012-06-08
Possible Cytarabine side effects in female
Reported by a physician from Netherlands on 2012-07-17
Patient: female, weighing 73.0 kg (160.6 pounds)
Reactions: Pneumonia, Respiratory Failure, Pancytopenia, Thrombocytopenia, Cerebral Haemorrhage, Influenza
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 225 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-10
End date: 2012-05-12
Clofarabine
Dosage: 19 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
End date: 2012-05-11
Cytarabine
Dosage: 3800 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2012-05-07
End date: 2012-05-12
Other drugs received by patient: Amphotericin B; Meropenem; Vancomycin
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-17
Patient: 50 year old female
Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Pancytopenia, Petechiae, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis, Laryngospasm
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, on days 1-7
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2, on days 1-5
Indication: Acute Myeloid Leukaemia
Idarubicin Hydrochloride
Dosage: 12 mg/m2, on days 1-3
Indication: Acute Myeloid Leukaemia
Mitoxantrone Hydrochloride
Dosage: 10 mg/m2, on days 1-5
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-06
Patient: 49 year old female
Reactions: Neoplasm Malignant, Swelling, Pancytopenia, Rash, Neurological Symptom, Generalised Oedema
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 1df=auc5 also auc4
Indication: Peritoneal Carcinoma Metastatic
Cyclophosphamide
Dosage: cyclophosphamide hydrate day1 also 600mg/m2
Indication: Peritoneal Carcinoma Metastatic
Cytarabine
Indication: Peritoneal Carcinoma Metastatic
Docetaxel
Indication: Peritoneal Carcinoma Metastatic
Doxil
Indication: Peritoneal Carcinoma Metastatic
Epirubicin Hydrochloride
Dosage: day1
Indication: Peritoneal Carcinoma Metastatic
Irinotecan HCL
Dosage: on day 1, 15
Indication: Peritoneal Carcinoma Metastatic
Methotrexate
Indication: Peritoneal Carcinoma Metastatic
Mitomycin
Dosage: inj
Indication: Peritoneal Carcinoma Metastatic
Nedaplatin
Dosage: also 60mg/m2,12mg/m2(days1-15),120mg/m2
Indication: Peritoneal Carcinoma Metastatic
Paclitaxel
Indication: Peritoneal Carcinoma Metastatic
Prednisolone
Indication: Peritoneal Carcinoma Metastatic
Possible Cytarabine side effects in 77 year old male
Reported by a consumer/non-health professional from Japan on 2012-07-06
Patient: 77 year old male, weighing 57.0 kg (125.4 pounds)
Reactions: Sepsis, Circulatory Collapse, Febrile Neutropenia, Pancytopenia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-19
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-19
Oncovin
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-08-23
End date: 2010-08-30
Pinorubin
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-08-23
End date: 2010-08-25
Prednisolone
Dosage: 10mg/day 28may10-19aug10,23aug10-31aug10
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-28
End date: 2010-08-31
Sprycel
Dosage: 70mg 2/1d 28jun-05jul 50mg 1/1d 06jul-22aug10 reduced 140mg to 50mg
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-06-28
End date: 2010-08-22
Other drugs received by patient: Lasix; Sodium Bicarbonate; Neutrogin; Diamox; Famotidine; Pursennid
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06
Patient: 50 year old female
Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Petechiae, Pancytopenia, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Death, Panniculitis, Colitis, Thrombocytopenia, Laryngospasm, Klebsiella Sepsis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2 on d1-7; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Idarubicin HCL
Dosage: 12 mg/m2 on d1-3; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Immune Globulin NOS
Indication: Pancytopenia
Mitoxantrone
Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Vercyte
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06
Patient: 50 year old female
Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Petechiae, Febrile Neutropenia, Pancytopenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2 on d1-7; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Idarubicin HCL
Dosage: 12 mg/m2 on d1-3; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Mitoxantrone
Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Vercyte
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-06
Patient: 50 year old female
Reactions: Haemoptysis, Refractoriness To Platelet Transfusion, Pancytopenia, Petechiae, Febrile Neutropenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Klebsiella Sepsis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2 on d1-7; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Idarubicin HCL
Dosage: 12 mg/m2 on d1-3; induction chemotherapy
Indication: Acute Myeloid Leukaemia
Mitoxantrone
Dosage: 10 mg/m2 on d1-5; 2nd induction chemotherapy
Indication: Acute Myeloid Leukaemia
Other drugs received by patient: Vercyte
Possible Cytarabine side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-29
Patient: 50 year old female
Reactions: Mouth Haemorrhage, Haemoptysis, Acute Myeloid Leukaemia, Petechiae, Febrile Neutropenia, Pancytopenia, Pyrexia, Alveolitis Allergic, Panniculitis, Colitis, Thrombocytopenia, Laryngospasm, Klebsiella Sepsis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Cytarabine
Dosage: 100 mg/m2, on days 1 to 7
Indication: Acute Myeloid Leukaemia
Etoposide
Dosage: 100 mg/m2 on days 1-5
Indication: Acute Myeloid Leukaemia
Idarubicin HCL
Dosage: 12 mg/m2, on days 1 and 3
Indication: Acute Myeloid Leukaemia
Mitoxantrone
Dosage: 10 mg/m2, unk
Indication: Acute Myeloid Leukaemia
Possible Cytarabine side effects in male
Reported by a physician from Netherlands on 2012-06-28
Patient: male, weighing 82.0 kg (180.4 pounds)
Reactions: Rash Generalised, Hyperacusis, Angina Pectoris, Pancytopenia, Staphylococcal Sepsis, Speech Disorder, Multi-Organ Failure, Central Nervous System Haemorrhage, Transient Ischaemic Attack, Jugular Vein Thrombosis, Septic Shock
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Amsacrine
Dosage: 220 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-10-31
End date: 2011-11-02
Cytarabine
Dosage: 1850 mg, bid
Start date: 2011-10-28
End date: 2011-11-02
Cytarabine
Dosage: 360 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-09-23
End date: 2011-09-29
Evoltra
Dosage: 18 mg, unk (cycle 1)
Indication: Acute Myeloid Leukaemia
Start date: 2011-09-23
End date: 2011-09-27
Evoltra
Dosage: 18 mg, unk (cycle 2)
Start date: 2011-10-28
End date: 2011-11-01
Idarubicin HCL
Dosage: 22 mg, unk
Indication: Acute Myeloid Leukaemia
Start date: 2011-09-23
End date: 2011-09-25
Possible Cytarabine side effects in 49 year old female
Reported by a consumer/non-health professional from Japan on 2012-06-25
Patient: 49 year old female
Reactions: Neoplasm Malignant, Swelling, Pancytopenia, Rash, Neurological Symptom, Generalised Oedema
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 1df=auc5 also auc4
Indication: Peritoneal Carcinoma Metastatic
Cyclophosphamide
Dosage: cyclophosphamide hydrate day1 also 600mg/m2
Indication: Peritoneal Carcinoma Metastatic
Cytarabine
Indication: Peritoneal Carcinoma Metastatic
Docetaxel
Indication: Peritoneal Carcinoma Metastatic
Doxil
Indication: Peritoneal Carcinoma Metastatic
Epirubicin Hydrochloride
Dosage: day1
Indication: Peritoneal Carcinoma Metastatic
Irinotecan HCL
Dosage: on day 1, 15
Indication: Peritoneal Carcinoma Metastatic
Methotrexate
Indication: Peritoneal Carcinoma Metastatic
Mitomycin
Dosage: inj
Indication: Peritoneal Carcinoma Metastatic
Nedaplatin
Dosage: also 60mg/m2,12mg/m2(days1-15),120mg/m2
Indication: Peritoneal Carcinoma Metastatic
Paclitaxel
Indication: Peritoneal Carcinoma Metastatic
Prednisolone
Indication: Peritoneal Carcinoma Metastatic
Page 1 Next >>
|